Clinical Trial Update: Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection [Phase 1]

View source ↗

Summary

This update describes a Phase 1 clinical trial investigating a neoantigen vaccine in patients with resectable esophageal cancer following neoadjuvant therapy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Neoantigen vaccine

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Resectable Esophageal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING